Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Svea Vaccin AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 11,438 More Arrow 18,095 Less Arrow 15,200
Financial expenses 10 Less Arrow 5 Less Arrow 0
Earnings before taxes -2,168 More Arrow 1,492 More Arrow 1,685
EBITDA -2,078 More Arrow 1,513 More Arrow 1,620
Total assets 1,990 More Arrow 4,166 Less Arrow 3,348
Current assets 1,410 More Arrow 3,860 Less Arrow 3,052
Current liabilities 1,607 More Arrow 2,426 Less Arrow 1,866
Equity capital 383 More Arrow 1,581 Less Arrow 1,394
- share capital 9 Equal arrow 9 Equal arrow 9
Employees (average) 94 Less Arrow 91 Less Arrow 65

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 19.2% More Arrow 38.0% More Arrow 41.6%
Turnover per employee 122 More Arrow 199 More Arrow 234
Profit as a percentage of turnover -19.0% More Arrow 8.2% More Arrow 11.1%
Return on assets (ROA) -108.4% More Arrow 35.9% More Arrow 50.3%
Current ratio 87.7% More Arrow 159.1% More Arrow 163.6%
Return on equity (ROE) -566.1% More Arrow 94.4% More Arrow 120.9%
Change turnover -6,042 More Arrow 2,850 Less Arrow -5,815
Change turnover % -35% More Arrow 19% Less Arrow -28%
Chg. No. of employees 3 More Arrow 26 Less Arrow -15
Chg. No. of employees % 3% More Arrow 40% Less Arrow -19%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.